For the findings, the researchers conducted this exploratory study on a group of 77 patients with COVID-19 in Wuhan, China.The drug combination tested in the trial included - interferon beta-1b, lopinavir, ritonavir and ribavirin
from Livemint - News https://ift.tt/2X5nuas
https://ift.tt/eA8V8J
from Livemint - News https://ift.tt/2X5nuas
https://ift.tt/eA8V8J
Post a Comment